1. Home
  2. NTRB

as of 12-02-2025 4:00pm EST

$4.62
$0.32
-6.48%
Stocks Health Care Industrial Specialties Nasdaq

Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.

Chart Type:
Time Range:
Founded: 2016 Country:
United States
United States
Employees: N/A City: ORLANDO
Market Cap: 71.7M IPO Year: N/A
Target Price: $13.00 AVG Volume (30 days): 21.2K
Analyst Decision: Buy Number of Analysts: 1
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -2.88 EPS Growth: N/A
52 Week Low/High: $3.72 - $11.78 Next Earning Date: 12-03-2025
Revenue: $2,578,059 Revenue Growth: 42.92%
Revenue Growth (this year): 560.75% Revenue Growth (next year): 588.39%

AI-Powered NTRB Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated a day ago

AI Recommendation

hold
Model Accuracy: 69.86%
69.86%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Share on Social Networks: